Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edesa Biotech (EDSA) Equity Ratio (2016 - 2022)

Edesa Biotech's Equity Ratio history spans 10 years, with the latest figure at 0.67 for Q2 2022.

  • For Q2 2022, Equity Ratio fell 27.93% year-over-year to 0.67; the TTM value through Jun 2022 reached 0.67, down 27.93%, while the annual FY2021 figure was 0.9, 45.31% up from the prior year.
  • Equity Ratio for Q2 2022 was 0.67 at Edesa Biotech, down from 0.83 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.95 in Q4 2018 and bottomed at 0.3 in Q2 2018.
  • The 5-year median for Equity Ratio is 0.8 (2021), against an average of 0.72.
  • The largest annual shift saw Equity Ratio crashed 68.56% in 2018 before it skyrocketed 199.74% in 2020.
  • A 5-year view of Equity Ratio shows it stood at 0.95 in 2018, then decreased by 12.06% to 0.83 in 2019, then decreased by 7.89% to 0.77 in 2020, then rose by 11.54% to 0.85 in 2021, then fell by 21.04% to 0.67 in 2022.
  • Per Business Quant, the three most recent readings for EDSA's Equity Ratio are 0.67 (Q2 2022), 0.83 (Q1 2022), and 0.85 (Q4 2021).